0001453814-19-000143.txt : 20191028 0001453814-19-000143.hdr.sgml : 20191028 20191028161846 ACCESSION NUMBER: 0001453814-19-000143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191028 FILED AS OF DATE: 20191028 DATE AS OF CHANGE: 20191028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kurtz Neil M CENTRAL INDEX KEY: 0001370350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34387 FILM NUMBER: 191173216 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES ROAD, SUITE 103 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medidata Solutions, Inc. CENTRAL INDEX KEY: 0001453814 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 522319066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 HUDSON ST., 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212.918.1800 MAIL ADDRESS: STREET 1: 350 HUDSON ST., 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 wf-form4_157229385318047.xml FORM 4 X0306 4 2019-10-28 1 0001453814 Medidata Solutions, Inc. MDSO 0001370350 Kurtz Neil M C/O MEDIDATA SOLUTIONS, INC. 350 HUDSON STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 Common Stock 2019-10-28 4 D 0 119161 92.25 D 0 D On October 28, 2019, pursuant to the Agreement and Plan of Merger, dated as of June 11, 2019, by and among Dassault Systemes SE ("DS"), Dassault Systemes Americas Corp., a Delaware corporation ("Parent"), 3DS Acquisition 6 Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and Medidata Solutions, Inc., a Delaware corporation (the "Issuer"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent and an indirect wholly-owned subsidiary of DS (the "Merger"). Disposed of pursuant to the Merger Agreement and by virtue of the Merger, in which each share of Medidata common stock, par value $0.01 per share ("Issuer Common Stock"), issued and outstanding immediately prior to the completion of the Merger (other than restricted share awards held by continuing employees) was converted into the right to receive $92.25 in cash and without interest (the "Merger Consideration"). /s/ Michael I. Otner, Attorney-in-Fact 2019-10-28